Female Longevity Hormone Panel

Description

What is the Pre-Conception Hormone Panel?

The Pre-Conception Hormone Panel from BiomarkersLabs.com is a comprehensive hormonal and nutritional assessment designed specifically for women planning pregnancy — providing a complete baseline evaluation of the key hormonal, nutritional, and metabolic factors that influence conception success, implantation, early pregnancy maintenance, and maternal and foetal health outcomes. Pre-conception optimisation is increasingly recognised as one of the highest-leverage clinical interventions in reproductive medicine, with evidence that addressing hormonal imbalances, nutritional deficiencies, thyroid dysfunction, and metabolic factors before conception significantly improves pregnancy rates, reduces miscarriage risk, and supports healthy foetal development.

This panel consolidates the most clinically relevant pre-conception investigations into a single comprehensive order, covering ovarian reserve (AMH), thyroid function (TSH, Free T4), reproductive hormones (FSH, LH, oestradiol, progesterone), iron and anaemia markers (ferritin, full blood count), folate and B12 status (critical for neural tube prevention), vitamin D, and metabolic screening (fasting glucose, HbA1c, fasting insulin where relevant) — providing the practitioner with a complete pre-conception health baseline from a single blood draw. Results are CLIA-certified (USA) and IVDR-compliant (EU/UK), delivered to the practitioner portal within 3–5 business days.

What does the Pre-Conception Hormone Panel measure?

AMH (Anti-Müllerian Hormone) — ovarian reserve assessment; the most important single fertility marker for women planning pregnancy, particularly in women over 35.

FSH (Follicle Stimulating Hormone) — ovarian reserve and gonadotropin axis; Day 2–3 testing.

LH (Luteinising Hormone) — LH:FSH ratio for PCOS screening and gonadotropin axis assessment.

Oestradiol (E2) — follicular phase oestrogen status; contextualises FSH interpretation.

Progesterone — Day 21 ovulation confirmation and luteal phase adequacy.

TSH (Thyroid Stimulating Hormone) — thyroid screening; thyroid dysfunction is among the most common and treatable causes of subfertility and miscarriage.

Free T4 — thyroid function confirmation where TSH is abnormal.

Prolactin — hyperprolactinaemia is a common and treatable cause of anovulatory subfertility.

Ferritin — iron stores; iron deficiency is common in women of reproductive age and impairs ovulatory function and pregnancy outcomes.

Vitamin D (25-OH) — vitamin D deficiency is associated with reduced implantation success and adverse pregnancy outcomes; supplementation is recommended in deficient women planning pregnancy.

Folate (RBC) — red cell folate reflects tissue folate stores; critical for neural tube defect prevention.

Vitamin B12 — B12 deficiency is associated with neural tube defects and adverse pregnancy outcomes; essential in vegetarian and vegan women.

HbA1c — uncontrolled pre-gestational diabetes significantly increases miscarriage and congenital anomaly risk; pre-conception glycaemic assessment is essential in women with risk factors.

Clinical indications

Pre-conception health assessment — the primary indication; a comprehensive hormonal and nutritional baseline for any woman planning pregnancy, enabling identification and correction of modifiable risk factors before conception.

Fertility investigation baseline — for women presenting with difficulty conceiving, this panel combines the core fertility markers (AMH, FSH, LH, oestradiol, progesterone, prolactin, TSH) with the nutritional and metabolic markers that influence fertility and early pregnancy outcomes.

Recurrent miscarriage — pre-conception workup — thyroid antibodies, progesterone, folate, vitamin B12, vitamin D, and HbA1c are all relevant to recurrent miscarriage risk; this panel provides a structured pre-conception screen before the next conception attempt.

Women over 35 planning pregnancy — AMH and Day 3 FSH are essential in women over 35 where ovarian reserve assessment directly influences the urgency and approach to fertility management.

Pre-IVF hormonal and nutritional baseline — as a complement to the specific IVF pre-treatment fertility workup, this panel ensures the full nutritional and metabolic picture is assessed alongside the ovarian reserve and reproductive hormone data.

Optimising pre-conception health in women with chronic disease — women with diabetes, thyroid disease, PCOS, or autoimmune conditions planning pregnancy benefit from a comprehensive pre-conception baseline that integrates hormonal, metabolic, and nutritional assessment.

Sample type and collection

Blood (serum and whole blood for HbA1c). Fasting required for HbA1c component (minimum 8 hours); other markers do not require fasting. Venepuncture at an approved collection site. Day 2–3 of the menstrual cycle is optimal for FSH, LH, and oestradiol. Day 21 is required for progesterone. AMH, TSH, ferritin, vitamin D, folate, B12, and HbA1c can be drawn on any day. Two blood draws across one cycle are ideal; however, a single Day 2–3 fasting morning draw covers the majority of the panel. Cycle day at draw must be documented on all samples.

Turnaround time

3–5 business days from specimen receipt.

Availability

USA · EU · UK · Canada

Compliance

CLIA Certified · IVDR Compliant · CE Marked · HIPAA Compliant · GDPR Compliant · PIPEDA Compliant

How to order

Register free at BiomarkersLabs.com. Licensed practitioners only. Pay per test — no subscription required. Results are delivered directly and securely to your practitioner portal and are never released directly to patients.